Amgen Launches Biomarker Assist(TM), a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing

Half of All Patients With NSCLC Have Oncogene Mutations, Yet Many Patients Are Not Tested to Screen for Biomarkers Professional Clinical Guidelines Recommend Broad Biomarker Testing for Actionable and Emerging Biomarkers, Including KRAS Biomarker Ass... Diagnostics, Oncology, Product Launch Amgen, Biomarker Assist, NSCLC
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news